These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22544431)

  • 1. An economic theory of the fourth hurdle.
    Rogowski WH
    Health Econ; 2013 May; 22(5):600-10. PubMed ID: 22544431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine.
    Rogowski WH; Hartz SC; John JH
    BMC Health Serv Res; 2008 Sep; 8():194. PubMed ID: 18816378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis.
    Fischer KE; Rogowski WH; Leidl R; Stollenwerk B
    Health Policy; 2013 Oct; 112(3):187-96. PubMed ID: 23664301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
    Marsh K; IJzerman M; Thokala P; Baltussen R; Boysen M; Kaló Z; Lönngren T; Mussen F; Peacock S; Watkins J; Devlin N;
    Value Health; 2016; 19(2):125-37. PubMed ID: 27021745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One of these things is not like the others: the idea of precedence in health technology assessment and coverage decisions.
    Giacomini M
    Milbank Q; 2005; 83(2):193-223. PubMed ID: 15960769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?
    Oliva-Moreno J; Puig-Junoy J; Trapero-Bertran M; Epstein D; Pinyol C; Sacristán JA
    Value Health; 2020 Jan; 23(1):25-31. PubMed ID: 31952669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economics and health technology assessment: perspectives from Australia and New Zealand.
    Streat S; Munn S
    Crit Care Clin; 2012 Jan; 28(1):125-33, vii. PubMed ID: 22123104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of health economic information by reimbursement authorities.
    Drummond MF
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii60-3. PubMed ID: 14585919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic evaluation of medical therapy--methodological principles].
    Szucs TD; Schramm W
    Zentralbl Chir; 1995; 120(8):577-83. PubMed ID: 7571888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
    Fenwick E; Steuten L; Knies S; Ghabri S; Basu A; Murray JF; Koffijberg HE; Strong M; Sanders Schmidler GD; Rothery C
    Value Health; 2020 Feb; 23(2):139-150. PubMed ID: 32113617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review.
    Hartz S; John J
    Int J Technol Assess Health Care; 2008; 24(4):465-72. PubMed ID: 18828942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [More care for a limited budget; a case for a better use of the efficiency criteria].
    Rutten FF; Brouwer WB
    Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation in cardiology.
    Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-making by healthcare payers.
    Levine M; Taylor R; Ryan M; Sculpher M
    Respir Med; 2002 Aug; 96 Suppl C():S31-8. PubMed ID: 12199490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Fourth hurdle reviews', NICE, and database applications.
    Paul JE; Trueman P
    Pharmacoepidemiol Drug Saf; 2001; 10(5):429-38. PubMed ID: 11802589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.